The Trump administration plans to pump millions of dollars into producing more medications in the U.S. as the coronavirus pandemic heightens longstanding concerns about the fragility of the global drug supply chain.
Freight-payment levels provide a good snapshot of current economic activity, and judging by the trend detected by U.S. Bank for the first quarter of this year, the news isn’t good.
PJ Bain, Chief Executive Officer of PrimeRevenue, reveals what insights can be gleaned about the state of global supply chains from a review of thousands of company invoices from around the world.
In this second annual Regional Guide to Global Supply Chain Management, you’ll find a series of reports and perspectives that shine a light on discrete parts of the world — and what it takes to keep product flowing between nations with disparate economics, regulatory regimes, and strengths and weaknesses.